Here’s what you need to know.
1. First quarter revenues increased by 10 percent year-over-year, topping $67.88 million. U.S. revenue reached $49.89 million in the first quarter of 2018, an 8 percent increase year over year.
2. K2M’s U.S. complex spine business saw an 8 percent growth year-over-year. In the first quarter of 2018, the segment brought in $18.51 million in revenue compared to $17.14 million in 2017.
3. The company’s minimally invasive segment grew from $7.87 million in revenue in the first quarter of 2017 to $8.38 million in the first quarter of 2018, a 6.4 percent increase year over year.
4. Following the same pattern of growth, the regenerative segment revenue increased by 8.5 percent year over year, from $21.2 million in the first quarter of 2017 to $23 million in the first quarter of 2018.
5. K2M expects 2018 full-year revenues to be between $283 million and $287 million, representing a 10 percent to 11 percent increase in year-over-year growth.
More articles on devices and implants:
Zimmer Biomet presents new technology platform for spine business: 4 observations
Zimmer Biomet makes new partnership to expand implant access: 3 notes
NuVasive reports 4.6% Q1 revenue growth, $27.1M net loss: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
